US Physicalrapy Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $91.75
- Today's High:
- $93.79
- Open Price:
- $92.5
- 52W Low:
- $72.0309
- 52W High:
- $123.5827
- Prev. Close:
- $93.01
- Volume:
- 94299
Company Statistics
- Market Cap.:
- $1.39 billion
- Book Value:
- 32.594
- Revenue TTM:
- $575.01 million
- Operating Margin TTM:
- 11.8%
- Gross Profit TTM:
- $112.02 million
- Profit Margin:
- 5.3%
- Return on Assets TTM:
- 4.72%
- Return on Equity TTM:
- 7.61%
Company Profile
US Physicalrapy Inc had its IPO on 1992-05-28 under the ticker symbol USPH.
The company operates in the Healthcare sector and Medical Care Facilities industry. US Physicalrapy Inc has a staff strength of 3,570 employees.
Stock update
Shares of US Physicalrapy Inc opened at $92.5 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $91.75 - $93.79, and closed at $93.6.
This is a +0.63% increase from the previous day's closing price.
A total volume of 94,299 shares were traded at the close of the day’s session.
In the last one week, shares of US Physicalrapy Inc have slipped by -6.63%.
US Physicalrapy Inc's Key Ratios
US Physicalrapy Inc has a market cap of $1.39 billion, indicating a price to book ratio of 3.5789 and a price to sales ratio of 2.0893.
In the last 12-months US Physicalrapy Inc’s revenue was $575.01 million with a gross profit of $112.02 million and an EBITDA of $82.92 million. The EBITDA ratio measures US Physicalrapy Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, US Physicalrapy Inc’s operating margin was 11.8% while its return on assets stood at 4.72% with a return of equity of 7.61%.
In Q2, US Physicalrapy Inc’s quarterly earnings growth was a negative -26.7% while revenue growth was a positive 7.8%.
US Physicalrapy Inc’s PE and PEG Ratio
- Forward PE
- 30.1205
- Trailing PE
- 48.4427
- PEG
- 3.0103
Its diluted EPS in the last 12-months stands at $1.92 per share while it has a forward price to earnings multiple of 30.1205 and a PEG multiple of 3.0103. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into US Physicalrapy Inc’s profitability.
US Physicalrapy Inc stock is trading at a EV to sales ratio of 2.5116 and a EV to EBITDA ratio of 15.6134. Its price to sales ratio in the trailing 12-months stood at 2.0893.
US Physicalrapy Inc stock pays annual dividends of $1.68 per share, indicating a yield of 1.85% and a payout ratio of 67.73%.
Balance sheet and cash flow metrics
- Total Assets
- $999.58 million
- Total Liabilities
- $85.82 million
- Operating Cash Flow
- $-6979000.00
- Capital Expenditure
- $2.46 million
- Dividend Payout Ratio
- 67.73%
US Physicalrapy Inc ended 2024 with $999.58 million in total assets and $0 in total liabilities. Its intangible assets were valued at $999.58 million while shareholder equity stood at $488.50 million.
US Physicalrapy Inc ended 2024 with $23.10 million in deferred long-term liabilities, $85.82 million in other current liabilities, 172000.00 in common stock, $237.67 million in retained earnings and $506.70 million in goodwill. Its cash balance stood at $160.74 million and cash and short-term investments were $160.74 million. The company’s total short-term debt was $38,804,000 while long-term debt stood at $143.46 million.
US Physicalrapy Inc’s total current assets stands at $241.80 million while long-term investments were $12.23 million and short-term investments were $0. Its net receivables were $71.14 million compared to accounts payable of $3.67 million and inventory worth $0.
In 2024, US Physicalrapy Inc's operating cash flow was $-6979000.00 while its capital expenditure stood at $2.46 million.
Comparatively, US Physicalrapy Inc paid $0.68 in dividends in 2024.
Other key metrics
- Current Trading Price
- $93.6
- 52-Week High
- $123.5827
- 52-Week Low
- $72.0309
- Analyst Target Price
- $131.75
US Physicalrapy Inc stock is currently trading at $93.6 per share. It touched a 52-week high of $123.5827 and a 52-week low of $123.5827. Analysts tracking the stock have a 12-month average target price of $131.75.
Its 50-day moving average was $110.38 and 200-day moving average was $100.96 The short ratio stood at 8.42 indicating a short percent outstanding of 0%.
Around 159.2% of the company’s stock are held by insiders while 9554.7% are held by institutions.
Frequently Asked Questions About US Physicalrapy Inc
Similar Industry Stocks (Medical Care Facilities)
Most Active
Top Gainers
Top Losers
About
U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The company operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. It offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. The company was founded in 1990 and is based in Houston, Texas.